Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Puumala virus envelope glycoproteins Gn and Gc** are essential viral surface proteins encoded by the medium (M) segment of hantavirus genomes, including Puumala virus, a significant cause of hemorrhagic fever with renal syndrome in Europe. Together, Gn and Gc form spike complexes on the viral envelope, crucial for virion assembly, surface architecture, and facilitating viral cell entry. Gn is positioned membrane-distal and is involved in viral attachment, displaying pronounced antigenic diversity due to immune selection. Gc is a class II fusion protein, mediating membrane fusion between the viral envelope and host endosomal membranes, triggered by low pH, which is essential for viral entry. High-resolution structural studies have revealed their oligomeric organization and conformational changes. Both Gn and Gc are focal points for antiviral strategies, with neutralizing antibodies targeting them by blocking binding, fusion, or conformational rearrangements. Despite their high sequence diversity and structural flexibility posing challenges for vaccine and antibody design, they represent important targets for antiviral antibody responses and potential vaccine development.
Antibody-mediated neutralization (prevention of virus binding/fusion by steric hindrance or conformational blockade); Inhibition of pH-dependent membrane fusion through antibody blockade or fusion inhibitor binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Puumala virus envelope glycoproteins Gn and Gc (Gn/Gc).